Copaxone in therapy of remittent disseminated sclerosis patients
Twenty three remittent disseminated sclerosis patients have been observed for two years to study the influence of copaxone on clinical manifestations and course of their disease in relation to the state of membrane- destabilizing processes in erythrocytes.
Saved in:
Main Authors: | O. A. Kitcherova, L. I. Reikhert, S. M. Bychenko, A. A. Sokolova |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2008-09-01
|
Series: | Бюллетень сибирской медицины |
Subjects: | |
Online Access: | https://bulletin.ssmu.ru/jour/article/view/3503 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Positive and Negative Aspects of Copaxone ( Glatiramer acetate) Action on TC, TG HbA1c and Iron Levels in The Sera of Iraqi Women with Multiple Sclerosis in Baghdad
by: Baghdad Science Journal
Published: (2017-03-01) -
RESULTS OF AN OPEN-LABEL COMPARATIVE RANDOMIZED CLINICAL TRIAL OF AXOGLATIRAN® FS (F-SINTEZ, RUSSIA) EFFICIENCY AND SAFETY IN COMPARISON WITH COPAXONE®-TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD., ISRAEL) IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
by: F. A. Khabirov, et al.
Published: (2017-01-01) -
SAFETY OF NEUROAXIAL BLOCKADES AT SURGICAL DELIVERY IN PATIENTS WITH DISSEMINATED SCLEROSIS
by: E. N. Plakhotina, et al.
Published: (2012-04-01) -
Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01) -
The use of psychodiagnostic methods in the process of psychocorrection cures of a patient with the disseminated sclerosis
by: A. V. Subbotin, et al.
Published: (2009-02-01)